CTOs on the Move

Ion Beam Applications

www.iba-worldwide.com

 
IBA (Ion Beam Applications S.A.) is a global medical technology company focused on bringing integrated and innovative solutions for the diagnosis and treatment of cancer. The Company is the worldwide technology leader in the field of proton therapy, the most advanced form of radiation therapy available today. IBA’s proton therapy solutions are flexible and adaptable, allowing customers to choose from universal full-scale proton therapy centers as well as compact, single room systems. In addition, IBA also has a radiation dosimetry business and develops particle accelerators for the medical world and industry. Headquartered in Belgium and employing about 1200 people worldwide, IBA ...
  • Number of Employees: 1K-5K
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Similar Companies

Transitions Optical

At Transitions Optical we help people live more vibrant lives by enhancing their vision and the way they perceive light. We were the first to successfully commercialise a plastic photochromic lens in 1990 and our talented people continue to make significant advances in colour science and lens materials, creating a better photochromic experience that`s available to more people. Through our partnerships with optical industry leaders, we offer adaptive solutions in the widest selection of designs and materials, covering hundreds of lens combinations. Our industry leading eyeglass brands are well known; Transitions® Signature®, Transitions® Vantage® and Transitions® XTRActive®. And we don`t stop there; we also make adaptive sunwear and motorcycle helmet shields. Transitions Optical is part of the Essilor Group.

ProKidney

ProKidney, a pioneer in the treatment of chronic kidney disease (CKD) through innovations in cellular therapy, was founded in 2015 after a decade of research. ProKidney`s lead product candidate, REACT® (Renal Autologous Cell Therapy), is a first-of-its-kind, patented disease-modifying autologous cellular therapy with the potential to not only slow and stabilize the progression of CKD, but in some cases drive meaningful improvement in kidney function. REACT® has received Regenerative Medicine Advanced Therapy (RMAT) designation, as well as FDA and EMA guidance, supporting an immediate start to a global registrational program, which launched in the United States on schedule in January 2022. On January 18, 2022, ProKidney announced that it would become a publicly traded company via a business combination with Social Capital Suvretta Holdings Corp. III

U S Endoscopy

Founded in 1991, US Endoscopy is a privately held, family-owned company specializing in device design and manufacturing of accessories for GI endoscopy. Marlin Younker, US Endoscopy Founder and Co-Chairman, is a respected pioneer in the industry

Palo Alto Research Center

Palo Alto Research Center is a Palo Alto, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Physician Billing Service Bureau

Physician Billing Service Bureau is a Dearborn Heights, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.